Literature DB >> 10091627

Differential clinical and motor control function in a pair of monozygotic twins with Huntington's disease.

N Georgiou1, J L Bradshaw, E Chiu, A Tudor, L O'Gorman, J G Phillips.   

Abstract

We report a pair of monozygotic Huntington's disease (HD) twins who, although sharing identical CAG repeat lengths, not only present with marked differences in clinical symptoms but also behavioral abilities as measured by our experimental procedures. Both HD twins and two healthy control subjects were tested twice over 2 years. Patient A was generally more impaired at a motor level, whereas Patient B showed greater attentional impairment; Patient B, however, showed more progressive deterioration. The control subjects' performance remained consistent over the 2-year interval. Patient A clinically had the more hyperkinetic hypotonic variant of the disease, whereas Patient B, who was the more impaired, presented with a more hypokinetic hypertonic (rigid) variant. The influences of epigenetic pre- and postnatal environmental factors should not be ignored.

Entities:  

Mesh:

Year:  1999        PMID: 10091627     DOI: 10.1002/1531-8257(199903)14:2<320::aid-mds1018>3.0.co;2-z

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  17 in total

Review 1.  Role of manganese in neurodegenerative diseases.

Authors:  Aaron B Bowman; Gunnar F Kwakye; Elena Herrero Hernández; Michael Aschner
Journal:  J Trace Elem Med Biol       Date:  2011-10-01       Impact factor: 3.849

2.  Presentation and treatment of monozygotic twins with congenital central hypoventilation syndrome.

Authors:  Reshma Amin; Andrea Riekstins; Suhail Al-Saleh; Colin Massicotte; Allan L Coates; Ian MacLusky
Journal:  Can Respir J       Date:  2011 Mar-Apr       Impact factor: 2.409

Review 3.  "Pre-symptomatic" Huntington's disease.

Authors:  Kevin Duff; Leigh J Beglinger; Jane S Paulsen
Journal:  Handb Clin Neurol       Date:  2008

4.  How does the genetic assassin select its neuronal target?

Authors:  James C Stevens; Elizabeth M C Fisher; Simon Mead
Journal:  Mamm Genome       Date:  2011-03-04       Impact factor: 2.957

5.  A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington's disease.

Authors:  Andrew M Tidball; Miles R Bryan; Michael A Uhouse; Kevin K Kumar; Asad A Aboud; Jack E Feist; Kevin C Ess; M Diana Neely; Michael Aschner; Aaron B Bowman
Journal:  Hum Mol Genet       Date:  2014-12-08       Impact factor: 6.150

Review 6.  The role of genetics in the establishment and maintenance of the epigenome.

Authors:  Covadonga Huidobro; Agustin F Fernandez; Mario F Fraga
Journal:  Cell Mol Life Sci       Date:  2013-03-10       Impact factor: 9.261

7.  Mouse Huntington's disease homolog mRNA levels: variation and allele effects.

Authors:  Karen T Dixon; Jamie A Cearley; Jesse M Hunter; Peter J Detloff
Journal:  Gene Expr       Date:  2004

Review 8.  Genetic and environmental factors in the pathogenesis of Huntington's disease.

Authors:  Anton van Dellen; Anthony J Hannan
Journal:  Neurogenetics       Date:  2004-01-24       Impact factor: 2.660

9.  Intergeneration CAG expansion in a Wuhan juvenile-onset Huntington disease family.

Authors:  Yuan Liu; Yan Shen; He Li; Hui Wang; Zhen-Rong Yang; Yan Chen; Yan-Ping Tang
Journal:  Neurosci Bull       Date:  2007-07       Impact factor: 5.203

10.  Genotype-phenotype interactions in primary dystonias revealed by differential changes in brain structure.

Authors:  B Draganski; S A Schneider; M Fiorio; S Klöppel; M Gambarin; M Tinazzi; J Ashburner; K P Bhatia; R S J Frackowiak
Journal:  Neuroimage       Date:  2009-04-01       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.